Login / Signup

Topical Losartan for Treating Corneal Haze After Ultraviolet-A/Riboflavin Collagen Cross-Linking.

Emily Grace RodgersZaina Al-MohtasebAllison J Chen
Published in: Cornea (2024)
Topical losartan, a transforming growth factor-β inhibitor, is a potential treatment in clinically significant corneal haze following epithelium-off corneal CXL. This clinical experience highlights the potential efficacy of topical losartan as a novel therapeutic option in such cases, but further clinical studies are needed.
Keyphrases
  • wound healing
  • transforming growth factor
  • angiotensin ii
  • epithelial mesenchymal transition
  • optical coherence tomography
  • human health
  • signaling pathway
  • cataract surgery
  • smoking cessation